Lexapro SSRI Antidepressant | Lawsuit, Lawyer | Side Effects: Birth Defects (Skeletal, Neural Tube, Heart, and Limb Birth Defects, Cleft Lip, Cleft Palate), Suicidal Behavior, and Serotonin Syndrome | Other SSRI Antidepressants: Effexor, Paxil, Prozac, Wellbutrin, Zoloft, and Zyban
Gilman Law LLP, a leading national law firm with over 30 years of experience protecting the rights of victims, is now accepting claims for lawsuits involving side effects such as birth defects, suicidal behavior, and Serotonin Syndrome associated with the use of the antidepressant, Lexapro.
If you or someone you know has taken the SSRi Lexapro during pregnancy and the birth child was born with a birth defect, skeletal defect, neural tube defect, heart defect, limb birth defects, cleft lip or cleft palate, or you have developed suicidal behavior, or serotonin syndrome, you may be a victim of a SSRi side effect.
Lexapro Side Effects and Symptoms
Birth Defects: Lexapro has been found to increase the risk of serious birth defects, including septal heart defects, Persistent Pulmonary Hypertension of Newborn (PPN), abdominal, limb, skull and skeletal defects, club foot, and cleft lip and palate.
Suicidal thoughts and behavior: In 2004 and 2006, the U.S. Food & Drug Administration (FDA) ordered antidepressant manufacturers, including the maker of Lexapro, to include suicide warnings on their labels.
Serotonin Syndrome: Patients prescribed Lexapro are at risk for serotonin toxicity, often referred to as Serotonin Syndrome.
FDA Warnings for Lexapro and Birth Defects
Recent studies on SSRIs like Lexapro and birth defects have found that such drugs allow too much serotonin to remain in the area where the cells of the fetus develop. The FDA issued a Lexapro birth defect warning in 2006. Some of the birth defects that might be attributed to Lexapro include club foot, cleft lip or palate, PPHN, neural tube defects, abdominal, skull and limb abnormalities, and heart defects.
FDA Warnings for Lexapro and Suicide
As early as 1990, people reported that antidepressants caused increased suicidal thoughts and behaviors. In 2004, the FDA mandated that the makers of Lexapro and similar antidepressants include a Black Box warning on their labels regarding their association with suicidal behavior in children. In 2006, the FDA analyzed the results of 372 studies of antidepressants, finding that even young adults (ages 18-25) were also afflicted with behavioral changes. As a result, the Black Box warning was modified to include this group of patients.
Lexapro and Serotonin Syndrome
According to the FDA, use of Lexapro with other drugs known as 5-hydroxytryptamine receptor agonists (triptans) can result in a life threatening condition called Serotonin Syndrome. Serotonin Syndrome causes serious changes in how the brain, muscles, and digestive system work.
What is Lexapro?
Lexapro, known generically as escitalopram, is a Selective Serotonin Reuptake Inhibitor (SSRIs). SSRIs prevent receptors in the human brain from absorbing serotonin that has already been released. Lexapro is used to treat depression and anxiety disorders, and is also used off-label as a smoking cessation aid. In September 2010, Forest Labs, the maker of Lexapro, settled a lawsuit with the U.S. Department of Justice that alleged, among other things, that it had illegally promoted off-label use of Lexapro, specifically for use in pediatric patients.
Legal Help for Victims of Lexapro Side Effects
If you or someone you know suffered from birth defects, suicidal behavior or Serotonin Syndrome that could be linked to Lexapro, Gilman Law is here to help. For a free evaluation of your case, please fill out the online form on the left or call Toll Free at 1-888-252-0048.